公司資料
Virpax Pharmaceuticals 股價、新聞與催化劑
- 股票代碼:
- VRPX
- 交易所:
- NASDAQ
- 產業:
- Biopharma
- 所在地:
- United States
股票表現
0.00 USD (0.00%)
收盤價
最後更新: 2026年8月14日
—
市值
股價為何變動
Current closing-price context is not available for VRPX.
公司概覽
業務概覽
Virpax Pharmaceuticals is a specialty pharmaceutical company focused on non-opioid pain management and advanced drug-delivery concepts. Its story is built around addressing pain with differentiated formulations and delivery systems rather than traditional systemic therapy.
所在地與產業分類
Virpax is headquartered in the United States and listed on NASDAQ. It sits in specialty pharma and drug-delivery development.
商業模式特徵
The company depends on clinical development, regulatory pathway clarity, and the ability to create value from a narrow pain portfolio. Investors usually watch formulation progress, safety, and commercialization options.
生技產業定位
Virpax occupies a small pain-management niche within biotech-adjacent specialty pharma. The stock is sensitive to proof that its delivery approach can matter in a crowded pain market.
未來催化劑
- Virpax’s catalysts are pain and CNS delivery programs, plus any update that clarifies whether the company can still keep the platform credible. The next step matters because the stock is still data-sensitive.
近期新聞
相似股票
商業成熟度、治療領域或催化劑模式相近的同業公司。